Get started
Author

K. Schäfer-Eckart

Observed names: K Schafer-Eckart, K Schäfer-Eckart, Karin Schäfer‐Eckart
Institution: Nuremberg Hospital
OpenAlex ID: A5110169216
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia
2012 · H Pfeifer, B Wassmann, et al. · Leukemia · 237
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
2012 · S K Metzelder, T Schroeder, et al. · Leukemia · 229
Karyotype complexity and prognosis in acute myeloid leukemia
2016 · F Stölzel, B Mohr, et al. · Blood Cancer Journal · 111
PDF
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia
2015 · C Müller-Tidow, P Tschanter, et al. · Leukemia · 49
Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation
2001 · Andreas Jenke, Ulf Renner, et al. · Clinical Transplantation · 48
A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients
2016 · L.M. Biehl, A. Huth, et al. · Annals of Oncology · 45
PDF
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)
2003 · Nicolaus Kröger, Hermann Einsele, et al. · Bone Marrow Transplantation · 40
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
2018 · C. Röllig, M. Kramer, et al. · Annals of Oncology · 37
PDF
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
2015 · J M Middeke, R Herbst, et al. · Leukemia · 36
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.
2004 · J Casper, W Knauf, et al. · PubMed · 24
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative forFLT3-ITD,NPM1- or biallelicCEBPA mutations
2017 · K. Heidrich, C. Thiede, et al. · Annals of Oncology · 18
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)
2015 · A. Thiel, J. Schetelig, et al. · Annals of Oncology · 12
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
1996 · A R Zander, W Krüger, et al. · PubMed · 4
A Comparative Study of Three Different Bioactive Glass Scaffolds Tailored for Cartilage Tissue Engineering
2024 · C. Gögele, S. Müller, et al. · Orthopaedic Proceedings · 2
Co-culture of Mesenchymal Stromal Cells and Ligamentocytes on Triphasic Embroidered Scaffolds for Anterior Cruciate Ligament Enthesis Tissue Engineering
2023 · C. Gögele, J. Vogt, et al. · Orthopaedic Proceedings
Thrombozytenrefraktärität
2015 · H. Wandt, K. Schäfer-Eckart · Transfusionsmedizin
Rationale Indikationsstellung zur Thrombozytenkonzentrat-Transfusion
2015 · H. Wandt, K. Schäfer-Eckart, et al. · Transfusionsmedizin
Works count: 17
Citation count: 892
H-index: 12
I10-index: 12
Year
Topic
Type